SciELO - Scientific Electronic Library Online

 
vol.29 número4Mejora genética de microtubérculos de papa in vitro mediante irradiación gammaApuntes sobre la patógenesis del VIH, su terapia y eliminación índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Biotecnología Aplicada

versión On-line ISSN 1027-2852

Resumen

LOPEZ-MOLA, Ernesto. Heberprot-P®: an idea turned into a product. Biotecnol Apl [online]. 2012, vol.29, n.4, pp.262-265. ISSN 1027-2852.

Diabetes mellitus has become a significant health problem throughout the world, where it constitutes the underlying cause for 84% of lower limb amputations due to recalcitrant ulcers. The Center for Genetic Engineering and Biotechnology (CIGB) at Havana, Cuba has designed an integrated strategy for preclinical testing, pharmaceutical development, production, clinical trials and business negotiations of an injectable drug for treating diabetic foot ulcers, denominated Heberprot-P®. This product, which uses epidermal growth factor as active ingredient and avoids these amputations, is the only registered drug of its type and has already had considerable medical, social and economic impact in Cuba and other nations, placing national science and the Cuban health system at the forefront of the fight against this disorder. Phase III trials are planned for 2013, pending approval of the Advisory Scientific Council of the European Medicines Agency (EMA), for examining its efficacy and safety in this continent. Research teams at CIGB continue to develop new Heberprot-P® versions, based on advanced controlled release systems employing micro and nanospheres, in order to continuously improve the product and extend its existing intellectual property coverage beyond the year 2030.

Palabras clave : Heberprot-P; pharmaceutical development; epidermal growth factor; infiltration; diabetes mellitus; diabetic foot ulcer; amputation.

        · resumen en Español     · texto en Inglés     · Inglés ( pdf )